Doyle James Edward

Avg. Two Year Performance

691% Avg. Purchase Return
181% Compound
(11%) Avg. Sale Return
(6%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return13%16%190%241%691%
Purchase Success Rate1 of 11 of 11 of 11 of 11 of 1
Average Sale Return3%(2%)(10%)(15%)(11%)
Sale Success Rate4 of 92 of 92 of 92 of 90 of 9
Drugs » Biotechnology

Director:

Holdings: 55.55K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--